About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [143 citations: 1–100 of 142 articles]

Articles published in Chemotherapy Research and Practice have been cited 143 times. The following is a list of the 142 articles that have cited the articles published in Chemotherapy Research and Practice.

  • Youngseok Lee, Jian Ma, Hui Lyu, Jingcao Huang, and Aeree Kim, “Role of erbB3 receptors in cancer therapeutic resistance,” Acta Biochimica et Biophysica Sinica, vol. 46, no. 3, pp. 190–198, 2014. View at Publisher · View at Google Scholar
  • Margherita Ratti, “Emerging combination therapies to overcome resistance in EGFR-driven tumors,” Anti-Cancer Drugs, vol. 25, no. 2, pp. 127–139, 2014. View at Publisher · View at Google Scholar
  • Sandhya V. G. Nair, Menik Hettihewa, and H. P. Vasantha Rupasinghe, “Apoptotic and Inhibitory Effects on Cell Proliferation of Hepatocellular Carcinoma HepG2 Cells by Methanol Leaf Extract of Costus speciosus,” BioMed Research International, vol. 2014, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Rajiv P. Gude, “Pentoxifylline regulates the cellular adhesion and its allied receptors to extracellular matrix components in breast cancer cells,” Biomedicine & Pharmacotherapy, vol. 68, no. 1, pp. 93–99, 2014. View at Publisher · View at Google Scholar
  • Liyan Jiang, Wei Zhu, Katie Streicher, Chris Morehouse, Philip Brohawn, Xiaoxiao Ge, Zhengwei Dong, Xiaolu Yin, Guanshan Zhu, Yi Gu, Koustubh Ranade, Brandon W. Higgs, and Jiaqi Huang, “Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lo wer epithelial-mesenchymal transition signature and longer survival in squa mous cell lung carcinoma,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Malgorzata K. Tuxen, and Dorte Lisbet Nielsen, “A systematic review of dual targeting in HER2-positive breast cancer,” Cancer Treatment Reviews, vol. 40, no. 2, pp. 259–270, 2014. View at Publisher · View at Google Scholar
  • Giuseppe Bronte, Christian Rolfo, Elisa Giovannetti, Giuseppe Cicero, Patrick Pauwels, Francesco Passiglia, Marta Castiglia, Sergio Rizzo, Francesca Lo Vullo, Eugenio Fiorentino, and Jan Van Meerbeeck, “Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clini cal aspects,” Critical Reviews in Oncology Hematology, vol. 89, no. 2, pp. 300–313, 2014. View at Publisher · View at Google Scholar
  • Megan Lyle, and Georgina V. Long, “The role of systemic therapies in the management of melanoma brain metastases,” Current Opinion in Oncology, vol. 26, no. 2, pp. 222–229, 2014. View at Publisher · View at Google Scholar
  • K. Chanprapaph, V. Vachiramon, and P. Rattanakaemakorn, “Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management,” Dermatology Research and Practice, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Fatima el Bahhaj, Frank J. Dekker, Nadine Martinet, and Philippe Bertrand, “Delivery of epidrugs,” Drug Discovery Today, 2014. View at Publisher · View at Google Scholar
  • Mi Ryoung Choi, and Nam Jin Yoo, “Oncogenic ERBB3 mutations altering p.Val104 is rare in acute leukemias and non-Hodgkin lymphomas,” European Journal of Haematology, vol. 92, no. 2, pp. 177–178, 2014. View at Publisher · View at Google Scholar
  • Poonam Sharma, Pawas Goswami, Vikas Sangwan, and Rameshwar Singh, “Antibiotic resistance among commercially available probiotics,” Food Research International, vol. 57, pp. 176–195, 2014. View at Publisher · View at Google Scholar
  • Yang Xiang, Xirun Wan, Fengzhi Feng, and Tong Ren, “Analysis of the Prognosis and Related Factors for Patients With Stage IV Ge stational Trophoblastic Neoplasia,” International Journal of Gynecological Cancer, vol. 24, no. 3, pp. 594–599, 2014. View at Publisher · View at Google Scholar
  • Gershon Volpin, Miri Cohen, Michael Assaf, Tamar Meir, Rina Katz, and Shimon Pollack, “Cytokine Levels (IL-4, IL-6, IL-8 and TGFβ) as Potential Biomarkers of Systemic Inflammatory Response in Trauma Patients,” International Orthopaedics, 2014. View at Publisher · View at Google Scholar
  • Shutao Guo, Lei Miao, and Yuhua Wang, “Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy,” Journal of Controlled Release, vol. 174, pp. 137–142, 2014. View at Publisher · View at Google Scholar
  • Farshad Homayouni Moghadam, Maryam Dehghan, Ehsan Zarepur, Reyhaneh Dehlavi, Fatemeh Ghaseminia, Shima Ehsani, Golnaz Mohammadzadeh, and Kazem Barzegar, “Oleo gum resin of Ferula assa-foetida L. ameliorates peripheral neuropathy in mice,” Journal of Ethnopharmacology, 2014. View at Publisher · View at Google Scholar
  • Henry D. Reyes, Kristina W. Thiel, Matthew J. Carlson, Xiangbing Meng, Shujie Yang, and Jean-Marie Stephan, “Comprehensive Profiling of EGFR/HER Receptors for Personalized Treatment of Gynecologic Cancers,” Molecular Diagnosis & Therapy, vol. 18, no. 2, pp. 137–151, 2014. View at Publisher · View at Google Scholar
  • Supratim Ghosh, Kamil B. Ucer, Ralph D'Agostino, Ken Grant, Joseph Sirintrapun, Michael J. Thomas, Roy Hantgan, and Manish Bharadwaj, “Non-covalent assembly of meso-tetra-4-pyridyl porphine with single-stranded DNA to form nano-sized complexes with hydrophobicity-dependent DNA release and anti-tumor activity,” Nanomedicine-Nanotechnology Biology and Medicine, vol. 10, no. 2, pp. 451–461, 2014. View at Publisher · View at Google Scholar
  • Haydar Ali Erken, Emine Rabia Koç, Haşmet Yazıcı, Arzu Yay, Gözde Özge Önder, and Saim Furkan Sarıcı, “Selenium Partially Prevents Cisplatin-Induced Neurotoxicity: A Preliminary Study,” NeuroToxicology, 2014. View at Publisher · View at Google Scholar
  • Carmine Pinto, Nicola Normanno, Lorenzo Capussotti, Francesco Cognetti, Alfredo Falcone, and Lorenzo Mantovani, “KRAS Early Testing: Consensus Initiative and Cost-Effectiveness Evaluation for Metastatic Colorectal Patients in an Italian Setting,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • Farah Khalil, and Scott Antonia, “PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells ,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Shu-Han Wu, Kuang-Li Lee, Ruei-Hung Weng, Zhao-Xian Zheng, and Arthur Chiou, “Dynamic Monitoring of Mechano-Sensing of Cells by Gold Nanoslit Surface Pla smon Resonance Sensor,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Milo Stanisic, “The Correlation between Pro- and Anti-Inflammatory Cytokines in Chronic Sub dural Hematoma Patients Assessed with Factor Analysis,” Plos One, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar
  • Naama Kanarek, Sergei I. Grivennikov, Michael Leshets, Audrey Lasry, Irit Alkalay, Elad Horwitz, Yoav D. Shaul, Matthew Stachler, Elena Voronov, Ron N. Apte, Michele Pagano, Eli Pikarsky, Sankar Ghosh, and Yinon Ben-Neriah, “Critical role for IL-1 beta in DNA damage-induced mucositis,” Proceedings of The National Academy of Sciences of The United States of Ame, vol. 111, no. 6, pp. E702–E711, 2014. View at Publisher · View at Google Scholar
  • Theresa M. Allen, and Pieter R. Cullis, “Liposomal drug delivery systems: From concept to clinical applications,” Advanced Drug Delivery Reviews, vol. 65, no. 1, pp. 36–48, 2013. View at Publisher · View at Google Scholar
  • Hardeep S. Oberoi, Natalia V. Nukolova, Alexander V. Kabanov, and Tatiana K. Bronich, “Nanocarriers for delivery of platinum anticancer drugs,” Advanced Drug Delivery Reviews, 2013. View at Publisher · View at Google Scholar
  • Andrew T. Chan, Reiko Nishihara, Charles S. Fuchs, Edward Giovannucci, Teppei Morikawa, Aya Kuchiba, Paul Lochhead, Kaori Shima, Ichiro Kawachi, Zhi Rong Qian, Mai Yamauchi, Xiaoyun Liao, Yu Imamura, and Katsuhiko Nosho, “A Prospective Study of Duration of Smoking Cessation and Colorectal Cancer Risk by Epigenetics-related Tumor Classification,” American Journal Of Epidemiology, vol. 178, no. 1, pp. 84–100, 2013. View at Publisher · View at Google Scholar
  • Ina Hohensee, Volkmar Mueller, Klaus Pantel, Sabine Riethdorf, Jakob Matschke, Manfred Westphal, Katrin Lamszus, Soenke Meyer-Staeckling, Isabell Witzel, Markus Glatzel, and Burkhard Brandt, “Frequent Genetic Alterations in EGFR- and HER2-Driven Pathways in Breast Ca ncer Brain Metastases,” American Journal Of Pathology, vol. 183, no. 1, pp. 83–95, 2013. View at Publisher · View at Google Scholar
  • Lifu Xiao, Mingjie Tang, Qifei Li, and Anhong Zhou, “Non-invasive detection of biomechanical and biochemical responses of human lung cells to short time chemotherapy exposure using AFM and confocal Raman spectroscopy,” Analytical Methods, vol. 5, no. 4, pp. 874–879, 2013. View at Publisher · View at Google Scholar
  • S. Roy, H. L. McLeod, L. S. Clark, A. Drobish, L. A. Carey, A. A. Motsinger-Reif, and E. C. Dees, “CYP2C8*3 increases risk of neuropathy in breast cancer patients treated wit h paclitaxel,” Annals Of Oncology, vol. 24, no. 6, pp. 1472–1478, 2013. View at Publisher · View at Google Scholar
  • S. Kim, M. Jary, L. Mansi, B. Benzidane, A. Cazorla, M. Demarchi, T. Nguyen, A. Kaliski, E. Delabrousse, F. Bonnetain, P. Letondal, J. F. Bosset, and S. Valmary-Degano, “DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising t reatment for recurrent advanced squamous cell anal carcinoma,” Annals of Oncology, vol. 24, no. 12, pp. 3045–3050, 2013. View at Publisher · View at Google Scholar
  • Antonio Ruggiero, Giovanna Trombatore, Silvia Triarico, Roberta Arena, Pietro Ferrara, Maria Scalzone, Filomena Pierri, and Riccardo Riccardi, “Platinum compounds in children with cancer,” Anti-Cancer Drugs, vol. 24, no. 10, pp. 1007–1019, 2013. View at Publisher · View at Google Scholar
  • Senthilnathan Rajendran, and Rajendran Shanmugam Muthupalani, “Lack of RING Finger Domain (RFD) Mutations of the c-Cbl Gene in Oral Squamo us Cell Carcinomas in Chennai, India,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 2, pp. 1073–1075, 2013. View at Publisher · View at Google Scholar
  • Zahra Bahadoran, Zeinab Karimi, Anahita Houshiar-rad, and Hamid-Reza Mirzayi, “Dietary Phytochemical Index and the Risk of Breast Cancer: A Case Control S tudy in a Population of Iranian Women,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 5, pp. 2747–2751, 2013. View at Publisher · View at Google Scholar
  • Meltem Demirel Kars, Ufuk Gündüz, Kamil Üney, and Ahmet Levent BaŞ, “Exploring a natural MDR reversal agent: potential of medicinal food supplement Nerium oleander leaf distillate,” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 8, pp. 644–649, 2013. View at Publisher · View at Google Scholar
  • Chuchard Punsawad, “Effect of malaria components on blood mononuclear cells involved in immune response,” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 9, pp. 751–756, 2013. View at Publisher · View at Google Scholar
  • Takashi Hoshiba, and Masaru Tanaka, “Breast cancer cell behaviors on staged tumorigenesis-mimicking matrices derived from tumor cells at various malignant stages,” Biochemical and Biophysical Research Communications, 2013. View at Publisher · View at Google Scholar
  • Gyoergy Varady, Judit Cserepes, Adrienn Nemeth, and Edit Szabo, “Cell surface membrane proteins as personalized biomarkers: where we stand a nd where we are headed,” Biomarkers in Medicine, vol. 7, no. 5, pp. 803–819, 2013. View at Publisher · View at Google Scholar
  • Dionysis Papadatos-Pastos, Aspasia Soultati, and Mark Harries, “Targeting Brain Metastases in Patients with Melanoma,” BioMed Research International, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • Dan Cao, Ye Chen, Yuan Tang, Xing-Chen Peng, Hang Dong, Long-Hao Li, Ke Cheng, Jun Ge, and Ji-Yan Liu, “Loss of RASSF1A Expression in Colorectal Cancer and Its Association with K-ras Status,” BioMed Research International, vol. 2013, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • Kari-Elise T. Codispoti, Stacy Mosier, Robert Ramsey, Ming-Tseh Lin, and Fausto J. Rodriguez, “Genetic and pathologic evolution of early secondary gliosarcoma,” Brain Tumor Pathology, 2013. View at Publisher · View at Google Scholar
  • Cynthia X. Ma, Vera J. Suman, Matthew Goetz, Paul Haluska, Timothy Moynihan, Rita Nanda, Olufunmilayo Olopade, Timothy Pluard, Zhanfang Guo, Helen X. Chen, Charles Erlichman, Matthew J. Ellis, and Gini F. Fleming, “A phase I trial of the IGF-1R antibody Cixutumumab in combination with tems irolimus in patients with metastatic breast cancer,” Breast Cancer Research and Treatment, vol. 139, no. 1, pp. 145–153, 2013. View at Publisher · View at Google Scholar
  • Ingar Seemann, Johannes A. M. te Poele, Ji-Ying Song, Saske Hoving, and Nicola S. Russell, “Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents,” Breast Cancer Research and Treatment, vol. 141, no. 3, pp. 385–395, 2013. View at Publisher · View at Google Scholar
  • M. Fujita, T. Kimura, K. Ogawa, C. P. Morrow, S. Kamiura, S. Mabuchi, M. Okazawa, Y. Matsumoto, and T. Tsutsui, “Utility of risk-weighted surgical-pathological factors in early-stage cervi cal cancer,” British Journal Of Cancer, vol. 108, no. 6, pp. 1348–1357, 2013. View at Publisher · View at Google Scholar
  • D. Gonzalez, L. Fearfield, P. Nathan, P. Taniere, A. Wallace, E. Brown, C. Harwood, J. Marsden, and S. Whittaker, “BRAF mutation testing algorithm for vemurafenib treatment in melanoma: reco mmendations from an expert panel,” British Journal of Dermatology, vol. 168, no. 4, pp. 700–707, 2013. View at Publisher · View at Google Scholar
  • Junya Zhu, Dhruv B. Sharma, Aileen B. Chen, Bruce E. Johnson, Jane C. Weeks, and Deborah Schrag, “Comparative effectiveness of three platinum-doublet chemotherapy regimens i n elderly patients with advanced nonsmall cell lung cancer,” Cancer, vol. 119, no. 11, pp. 2048–2060, 2013. View at Publisher · View at Google Scholar
  • Lixia Ju, “Integrin beta 1 enhances the epithelial-mesenchymal transition in associati on with gefitinib resistance of non-small cell lung cancer,” Cancer Biomarkers, vol. 13, no. 5, pp. 329–336, 2013. View at Publisher · View at Google Scholar
  • Lawrence H. Cheung, Walter N. Hittelman, Hideo Yagita, Jeffrey A. Winkles, Hong Zhou, and Stuart S. Martin, “Antitumor Activity of a Humanized, Bivalent Immunotoxin Targeting Fn14-Posi tive Solid Tumors,” Cancer Research, vol. 73, no. 14, pp. 4439–4450, 2013. View at Publisher · View at Google Scholar
  • Iris Eke, Katja Storch, and Mechthild Krause, “Cetuximab Attenuates Its Cytotoxic and Radiosensitizing Potential by Induci ng Fibronectin Biosynthesis,” Cancer Research, vol. 73, no. 19, pp. 5869–5879, 2013. View at Publisher · View at Google Scholar
  • D. C. Coraca-Huber, J. Hausdorfer, M. Fille, M. Steidl, and M. Nogler, “Effect of two cleaning processes for bone allografts on gentamicin impregna tion and in vitro antibiotic release,” Cell and Tissue Banking, vol. 14, no. 2, pp. 221–229, 2013. View at Publisher · View at Google Scholar
  • Valeria Maria Piccolini, Maria Grazia Bottone, Giovanni Bottiroli, Sandra Angelica De Pascali, and Francesco Paolo Fanizzi, “Platinum drugs and neurotoxicity: effects on intracellular calcium homeosta sis,” Cell Biology and Toxicology, vol. 29, no. 5, pp. 339–353, 2013. View at Publisher · View at Google Scholar
  • Samarth Hegde, “A Skin-depth Analysis of Integrins: Role of the Integrin Network in Health and Disease,” Cell Communication and Adhesion, vol. 20, no. 6, pp. 155–169, 2013. View at Publisher · View at Google Scholar
  • Bruna Corominas-Faja, Cristina Oliveras-Ferraros, Elisabet Cuyas, Antonio Segura-Carretero, Jorge Joven, Begona Martin-Castillo, Enrique Barrajon-Catalan, Vicente Micol, and Joaquim Bosch-Barrera, “Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell l ung cancer A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin,” Cell Cycle, vol. 12, no. 21, pp. 3390–3404, 2013. View at Publisher · View at Google Scholar
  • C. R. I. Lam, C. Tan, Z. Teo, C. Y. Tay, T. Phua, Y. L. Wu, P. Q. Cai, L. P. Tan, X. Chen, and P. Zhu, “Loss of TAK1 increases cell traction force in a ROS-dependent manner to dri ve epithelial-mesenchymal transition of cancer cells,” Cell Death & Disease, vol. 4, 2013. View at Publisher · View at Google Scholar
  • S Wansleben, E Davis, J Peres, and S Prince, “A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance,” Cell Death and Disease, vol. 4, no. 10, pp. e846, 2013. View at Publisher · View at Google Scholar
  • Fereshteh Mir Mohammadrezaei, Homa Mohseni Kouchesfehani, Hamed Montazeri, Mehdi Gharghabi, Seyed Nasser Ostad, and Mohammad Hossein Ghahremani, “Signaling crosstalk of FHIT, CHK2 and p38 in etoposide induced growth inhib ition in MCF-7 cells,” Cellular Signalling, vol. 25, no. 1, pp. 126–132, 2013. View at Publisher · View at Google Scholar
  • Dana S. Neel, and Trever G. Bivona, “Secrets of Drug Resistance in NSCLC Exposed by New Molecular Definition of EMT,” Clinical Cancer Research, vol. 19, no. 1, pp. 3–5, 2013. View at Publisher · View at Google Scholar
  • Cynthia Harrison, “Neurologic Complications of Cancer and Cancer Therapy,” Clinical Journal Of Oncology Nursing, vol. 17, no. 4, pp. 418–424, 2013. View at Publisher · View at Google Scholar
  • Tony K. L. Kiang, Kyle J. Wilby, and Mary H. H. Ensom, “Clinical Pharmacokinetic Drug Interactions Associated with Artemisinin Derivatives and HIV-Antivirals,” Clinical Pharmacokinetics, 2013. View at Publisher · View at Google Scholar
  • Vladimir P. Chekhonin, Anna A. Korchagina, Sergey A. Shein, and Olga I. Gurina, “VEGF in Tumor Progression and Targeted Therapy,” Current Cancer Drug Targets, vol. 13, no. 4, pp. 423–443, 2013. View at Publisher · View at Google Scholar
  • P. Warnault, G. Cheve, C. Bories, M. Coisy-Quivy, R. Benhida, A. Yasri, and B. Fauvel, “Recent Advances in Drug Design of Epidermal Growth Factor Receptor Inhibito rs,” Current Medicinal Chemistry, vol. 20, no. 16, pp. 2043–2067, 2013. View at Publisher · View at Google Scholar
  • Manuel Diezi, and Thierry Buclin, “Toxic and drug-induced peripheral neuropathies: updates on causes, mechanis ms and management,” Current Opinion in Neurology, vol. 26, no. 5, pp. 481–488, 2013. View at Publisher · View at Google Scholar
  • Nicolas Authier, Vanessa Pereira, Jeremy Ferrier, and Jerome Busserolles, “Emerging Trends in Understanding Chemotherapy-Induced Peripheral Neuropathy,” Current Pain And Headache Reports, vol. 17, no. 10, 2013. View at Publisher · View at Google Scholar
  • Devron R. Shah, Rashmi R. Shah, and Joel Morganroth, “Tyrosine Kinase Inhibitors: Their On-Target Toxicities as Potential Indicat ors of Efficacy,” Drug Safety, vol. 36, no. 6, pp. 413–426, 2013. View at Publisher · View at Google Scholar
  • Andrew D. Norden, Eudocia Q. Lee, Rameen Beroukhim, Lakshmi Nayak, Patrick Y. Wen, and Mikael L. Rinne, “Update on bevacizumab and other angiogenesis inhibitors for brain cancer,” Expert Opinion On Emerging Drugs, vol. 18, no. 2, pp. 137–153, 2013. View at Publisher · View at Google Scholar
  • Hebatallah Hassan, Burkhard Greve, Mauro S. G. Pavao, Ludwig Kiesel, Sherif A. Ibrahim, and Martin Goette, “Syndecan-1 modulates beta-integrin-dependent and interleukin-6-dependent fu nctions in breast cancer cell adhesion, migration, and resistance to irradi ation,” Febs Journal, vol. 280, no. 10, pp. 2216–2227, 2013. View at Publisher · View at Google Scholar
  • Mohammad Waseem, “Mitochondrial dysfunction mediated cisplatin induced toxicity: Modulatory r ole of curcumin,” Food And Chemical Toxicology, vol. 53, pp. 334–342, 2013. View at Publisher · View at Google Scholar
  • Jodee L. Johnson, and Elvira Gonzalez de Mejia, “Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro,” Food and Chemical Toxicology, 2013. View at Publisher · View at Google Scholar
  • Miguel Gueimonde, Borja Sanchez, and Clara G. de los Reyes-Gavilan, “Miguel Gueimonde, Borja Sonchez, Clara G. de los Reyes-Gavilan and Abelardo Margolies,” Frontiers in Microbiology, vol. 4, 2013. View at Publisher · View at Google Scholar
  • Satu Maki-Nevala, Virinder Kaur Sarhadi, Katja Tuononen, Sonja Lagstrom, Pekka Ellonen, Mikko Ronty, Aino Wirtanen, and Aija Knuuttila, “Mutated Ephrin Receptor Genes in Non-Small Cell Lung Carcinoma and Their Oc currence with Driver Mutations-Targeted Resequencing Study on Formalin-Fixe d, Paraffin-Embedded Tumor Material of 81 Patients,” Genes Chromosomes & Cancer, vol. 52, no. 12, pp. 1141–1149, 2013. View at Publisher · View at Google Scholar
  • R. DeMasi, Y. van Delft, and P. Mohammed, “Pharmacokinetic interaction between etravirine or darunavir/ritonavir and a rtemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-per iod, randomized trial,” Hiv Medicine, vol. 14, no. 7, pp. 421–429, 2013. View at Publisher · View at Google Scholar
  • Ke Li, Ling Tian, Yanli Luo, Qian Huang, Min Wang, and Ling Zhou, “Molecular markers of therapeutic resistance in breast cancer,” Human Pathology, vol. 44, no. 7, pp. 1421–1428, 2013. View at Publisher · View at Google Scholar
  • Monika E. Freiser, Paolo Serafini, and Donald T. Weed, “The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities,” Immunologic Research, 2013. View at Publisher · View at Google Scholar
  • Mika Okazawa, Seiji Mabuchi, Fumiaki Isohashi, Osamu Suzuki, Yasuo Yoshioka, Tomoyuki Sasano, Yukinobu Ohta, Shoji Kamiura, Kazuhiko Ogawa, and Tadashi Kimura, “Impact of the Addition of Concurrent Chemotherapy to Pelvic Radiotherapy in Surgically Treated Stage IB1-IIB Cervical Cancer Patients With Intermediat e-Risk or High-Risk Factors A 13-Year Experience,” International Journal of Gynecological Cancer, vol. 23, no. 3, pp. 567–575, 2013. View at Publisher · View at Google Scholar
  • Alberto Antonicelli, Stefano Cafarotti, Alice Indini, Alessio Galli, Andrea Russo, Alfredo Cesario, Filippo Maria Lococo, Patrizia Russo, Alberto Franco Mainini, Luca Giuseppe Bonifati, Mario Nosotti, Luigi Santambrogio, Stefano Margaritora, Pierluigi Maria Granone, and Andre Emanuel Dutly, “EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogen ic Mutation,” International Journal Of Medical Sciences, vol. 10, no. 3, pp. 320–330, 2013. View at Publisher · View at Google Scholar
  • Rafael Paletta-Silva, Nathália Rocco-Machado, and José Meyer-Fernandes, “NADPH Oxidase Biology and the Regulation of Tyrosine Kinase Receptor Signaling and Cancer Drug Cytotoxicity,” International Journal of Molecular Sciences, vol. 14, no. 2, pp. 3683–3704, 2013. View at Publisher · View at Google Scholar
  • Wenbin Lin, Demin Liu, and Chunbai He, “Application of liposomal technologies for delivery of platinum analogs in o ncology,” International Journal Of Nanomedicine, vol. 8, pp. 3309–3319, 2013. View at Publisher · View at Google Scholar
  • S. E. Salem, E. Dahdouh, and Z. Daoud, “Resistance of Gram-Negative Bacilli in Lebanon,” ISRN Infectious Diseases, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • V. Patil, V. Noronha, A. Joshi, Vamshi Muddu Krishna, S. Juvekar, Gauri Pantvaidya, Pankaj Chaturvedi, D. Chaukar, Supreeta Arya, Aswari Patil, B. Bhosale, A. Dongre, A. K. Dcruz, and K. Prabhash, “Is There a Limitation of RECIST Criteria in Prediction of Pathological Response, in Head and Neck Cancers, to Postinduction Chemotherapy?,” ISRN Oncology, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • Kentaro Tamaki, Nobumitsu Tamaki, Yoshihiko Kamada, Kano Uehara, Hisamitsu Zaha, Mai Onomura, Masanori Gushimiyagi, Kaname Kurashita, Keiko Miyazato, Hiromu Tengan, Kyuichiro Miyara, and Takanori Ishida, “The Challenge to Reduce Breast Cancer Mortality in Okinawa: Consensus of th e First Okinawa Breast Oncology Meeting,” Japanese Journal of Clinical Oncology, vol. 43, no. 2, pp. 208–213, 2013. View at Publisher · View at Google Scholar
  • Alejandro Bravo-Cuellar, Georgina Hernandez-Flores, Jorge Ramiro Dominguez-Rodriguez, Paulina Gomez-Lomeli, Luis F. Jave-Suarez, Ruth De Celis-Carrillo, Adriana Aguilar-Lemarroy, and Jose Manuel Lerma-Diaz, “Pentoxifylline and the proteasome inhibitor MG132 induce apoptosis in human leukemia U937 cells through a decrease in the expression of Bcl-2 and Bcl- XL and phosphorylation of p65,” Journal Of Biomedical Science, vol. 20, 2013. View at Publisher · View at Google Scholar
  • Nadereh Behtash, Fatemeh Gaemmaghami, Elahe Rezayof, Mitra M. Gillani, and Azam Sadat Moosavi, “The WHO score predicts treatment outcome in low risk gestational trophoblas tic neoplasia patients treated with weekly intramuscular methotrexate,” Journal Of Cancer Research And Therapeutics, vol. 9, no. 1, pp. 38–43, 2013. View at Publisher · View at Google Scholar
  • Hong-Quan Duong, Young Bin Hong, Jung Soon Kim, Hee-Seok Lee, Yong Weon Yi, Yeon Jeong Kim, Antai Wang, Wenjing Zhao, Chi Heum Cho, and Yeon-Sun Seong, “Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine,” Journal of Cellular and Molecular Medicine, vol. 17, no. 10, pp. 1261–1270, 2013. View at Publisher · View at Google Scholar
  • Hsin-Ling Yang, Kai-Yuan Lin, Ying-Chen Juan, K.J. Senthil Kumar, Tzong-Der Way, Pei-Chun Shen, Ssu-Ching Chen, and You-Cheng Hseu, “The anti-cancer activity of Antrodia camphorata against human ovarian carcinoma (SKOV-3) cells via modulation of HER-2/neu signaling pathway,” Journal of Ethnopharmacology, vol. 148, no. 1, pp. 254–265, 2013. View at Publisher · View at Google Scholar
  • Marina Elli, Stefania Arioli, Simone Guglielmetti, and Diego Mora, “Biocide susceptibility in bifidobacteria of human origin,” Journal of Global Antimicrobial Resistance, 2013. View at Publisher · View at Google Scholar
  • Tiangui Huang, Michael Karsy, Jian Zhuge, Minghao Zhong, and Delong Liu, “B-Raf and the inhibitors: from bench to bedside,” Journal of Hematology & Oncology, vol. 6, 2013. View at Publisher · View at Google Scholar
  • Julius Steffen, and Jan Steffen, “Driving Forces Behind the Past and Future Emergence of Personalized Medicine,” Journal of Personalized Medicine, vol. 3, no. 1, pp. 14–22, 2013. View at Publisher · View at Google Scholar
  • Shashi Rajput, B. N. Prashanth Kumar, Kaushik Kumar Dey, Ipsita Pal, and Aditya Parekh, “Molecular targeting of Akt by thymoquinone promotes G(1) arrest through tra nslation inhibition of cyclin D1 and induces apoptosis in breast cancer cel ls,” Life Sciences, vol. 93, no. 21, pp. 783–790, 2013. View at Publisher · View at Google Scholar
  • Suzanne E. Dahlberg, Joan H. Schiller, and David H. Johnson, “Does histology predict survival of advanced non-small cell lung cancer pati ents treated with platin-based chemotherapy? An analysis of the Eastern Coo perative Oncology Group Study E1594,” Lung Cancer, vol. 81, no. 1, pp. 47–52, 2013. View at Publisher · View at Google Scholar
  • Varune R. Ramnarine, Stephen Lam, and Wan L. Lam, “Genetic alterations defining NSCLC subtypes and their therapeutic implicati ons,” Lung Cancer, vol. 82, no. 2, pp. 179–189, 2013. View at Publisher · View at Google Scholar
  • Chi-Chao Liu, Pascal Leclair, and Shyong Quin Yap, “The Membrane-Proximal KXGFFKR Motif of alpha-Integrin Mediates Chemoresista nce,” Molecular and Cellular Biology, vol. 33, no. 21, pp. 4334–4345, 2013. View at Publisher · View at Google Scholar
  • Curtis R. Pickering, David M. Neskey, Mei Zhao, Marcus Vinicius Ortega Alves, Alison L. Fitzgerald, Jeffrey N. Myers, Mayur A. Gadhikar, Maria Rita Sciuto, and Abdullah A. Osman, “Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cance r Cells Secondary to the Loss of Functional p53,” Molecular Cancer Therapeutics, vol. 12, no. 9, pp. 1860–1873, 2013. View at Publisher · View at Google Scholar
  • Anjali Singh, Xueqing Lun, Aarthi Jayanthan, Halah Obaid, Yibing Ruan, Douglas Strother, Susan N. Chi, Amy Smith, Peter Forsyth, and Aru Narendran, “Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR- ErbB2 signaling with lapatinib,” Molecular Oncology, vol. 7, no. 3, pp. 497–512, 2013. View at Publisher · View at Google Scholar
  • Natalia V. Nukolova, Hardeep S. Oberoi, Yi Zhao, Vladimir P. Chekhonin, and Tatiana K. Bronich, “LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian Cancer,” Molecular Pharmaceutics, vol. 10, no. 10, pp. 3913–3921, 2013. View at Publisher · View at Google Scholar
  • Pranali P Deshpande, Swati Biswas, and Vladimir P Torchilin, “Current trends in the use of liposomes for tumor targeting,” Nanomedicine, vol. 8, no. 9, pp. 1509–1528, 2013. View at Publisher · View at Google Scholar
  • Giada Santin, Valeria M. Piccolini, Sergio Barni, Paola Veneroni, Vincenzo Giansanti, Veronica Dal Bo, Graziella Bernocchi, and Maria Grazia Bottone, “Mitochondrial fusion: A mechanism of cisplatin-induced resistance in neuroblastoma cells?,” NeuroToxicology, vol. 34, pp. 51–60, 2013. View at Publisher · View at Google Scholar
  • Pin Guo, Jin Lan, Jianwei Ge, and Qing Mao, “ID1 regulates U87 human cell proliferation and invasion,” Oncology Letters, vol. 6, no. 4, pp. 921–926, 2013. View at Publisher · View at Google Scholar
  • Abiodun Falodun, Nadja Engel, Udo Kragl, Barbara Nebe, and Peter Langer, “Novel anticancer alkene lactone from Persea americana,” Pharmaceutical Biology, vol. 51, no. 6, pp. 700–706, 2013. View at Publisher · View at Google Scholar
  • Yasuhito Onodera, and Jin-Min Nam, “Intracellular trafficking of integrins in cancer cells,” Pharmacology & Therapeutics, vol. 140, no. 1, pp. 1–9, 2013. View at Publisher · View at Google Scholar
  • Lu Jiang, Ting Lan, Yongchang Chen, Jianrong Sang, Yueying Li, Min Wu, Yan Tao, Ying Wang, Hai Qian, and Luo Gu, “PKG II Inhibits EGF/EGFR-Induced Migration of Gastric Cancer Cells,” Plos One, vol. 8, no. 4, 2013. View at Publisher · View at Google Scholar